ATYR PHARMA INC - COM (LIFE)

CUSIP: 002120103

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
10,593,036
Share change
-736,193
Total reported value
$5,252,974
Price per share
$0.50
Number of holders
23
Value change
-$586,521
Number of buys
6
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 002120103?
CUSIP 002120103 identifies LIFE - ATYR PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ATYR PHARMA INC - COM (LIFE) as of Q4 2018

As of 31 Dec 2018, ATYR PHARMA INC - COM (LIFE) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,593,036 shares. The largest 10 holders included FMR LLC, Polaris Venture Management Co. V, L.L.C., Viking Global Investors LP, RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, BlackRock Inc., Glen Harbor Capital Management LLC, Meadow Creek Investment Management LLC, ACADIAN ASSET MANAGEMENT LLC, and TWO SIGMA INVESTMENTS, LP. This page lists 23 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.